Skip to content

A health monitoring study of healthy meal intake in Japanese adults with level 1 or higher obesity level of the criteria by Japan Society for the Study of Obesity

A health monitoring study of healthy meal intake in Japanese adults with level 1 or higher obesity level of the criteria by Japan Society for the Study of Obesity - A health monitoring study of healthy meal intake in Japanese adults with level 1 or higher obesity level of the obesity criteria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023808
Enrollment
30
Registered
2016-08-29
Start date
2016-10-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese adults with level 1 or higher obesity of the criteria by Japan Society for the Study of Obesity

Interventions

To investigate changes in BMI, body weight, and vital signs at 2 and 4 weeks after taking the prescribed healthy meal (3 times a day + snack) for 28 days.

Sponsors

InCROM Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The subject who was given explanation about the objective, methods, study period, and expected detriment, etc. of this study, understood them, and gave informed consent on a voluntary basis. 2. The Japanese adult male or female aged 20 to 65 years, inclusive, at the time of informed consent 3. The subject whose BMI is 25.0 or over (level 1 or higher obesity level of the obesity criteria by Japan Society for the Study of Obesity) 4. The subject who can comply with the study rules and communicate subjective symptoms, etc.

Exclusion criteria

Exclusion criteria: 1. The subject who has hepatic, renal, cardiovascular, respiratory, endocrine system, metabolic, neurological, or psychiatric disorder, or who was assessed to have a past history of any of these diseases by the principal investigator or subinvestigators (excluding subjects with lifestyle related diseases including hypertension, dyslipidemia, or diabetes mellitus who were assessed eligible for this study by the principal investigator) 2. The subject who has drug or food allergy 3. The subject who has drug or alcohol dependence 4. In addition, the subject who was assessed ineligible for the study by the principal investigator or subinvestigators

Design outcomes

Primary

MeasureTime frame
Chages in BMI

Secondary

MeasureTime frame
Chages in body weights, vital signs, and clinical laboratory tests

Countries

Japan

Contacts

Public ContactHiroshi Mikami

Medical Corporation Heishinkai OPHAC Hospital Hospital Director

hiroshi.mikami@heishinkai.com06-6395-9000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026